2024-03-28T12:23:08Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_AF0CFA1DD218
2024-03-23T02:50:35Z
serval:BIB_AF0CFA1DD218
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
10.1007/s002280050009
10663454
000085066300009
Rousso
P.
author
Buclin
T.
author
Nussberger
J.
author
Brunner-Ferber
F.
author
Brunner
H.R.
author
Biollaz
J.
author
article
2000
European journal of clinical pharmacology
0031-6970
journal
55
10
749-54
Administration, Oral
Adult
Angiotensin-Converting Enzyme Inhibitors
Benzazepines
Biological Availability
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Infusions, Intravenous
Male
Protease Inhibitors
Pyridines
Renin
Time Factors
eng
60_published
peer-reviewed
Publication types: Clinical Trial ; Journal Article ; Randomized Controlled Trial - Publication Status: ppublish